Clinical Trials in Oncology: How Decentralization Improves Quality of Patient Care

Decentralized clinical trials (DCTs) can play a key role in increasing access and, ultimately, enhancing patient care within oncology clinical trials.

Accelerating Clinical Trials with a Strategic Decentralized Approach

Decentralized components can support and accelerate every stage of a trial, significantly decreasing time to completion without compromising safety or quality.

Augmented ePRO: A Practical Solution to an Industry-wide Problem

The subjectivity that characterizes ePRO can be challenging to overcome, compromising data accuracy and trial endpoints. We’ve responded to this industry-wide problem with a practical solution: Augmented ePRO. Our breakthrough offer combines the ease of ePRO with the accuracy of expert rating, all centralized in a single platform.

The Digital Trial Solution for Your Digital Therapeutic

For innovative digital therapeutic and diagnostic companies, traditional trial methods are antiquated – producing poor results in a slow and expensive way. You need a partner to develop a decentralized clinical trial that accelerates your timelines and works with your tech. Meet ObvioHealth.

ePRO Solutions Proven to Deliver Better Data

Effective ePRO solutions allow sponsors to gather quality data from participants in real time, so they can accurately assess how treatments impact patients.

Virtual Clinical Trials: Enhancing the Patient Experience with Digital Technologies

The best clinical virtual trials technologies support and enhance human connection and the patient experience. Learn how digitally enabled trials are empowering participants and study teams and delivering better data.

Decentralized Clinical Trial Platforms: The Tech Revolution Driving Greater Agency in the Clinical Trial Space

Decentralized clinical trial platforms solve challenges for sponsors, study teams, and patients. Learn how DCTs are revolutionizing the life sciences industry.

DCTs and Devices: Lessons Learned from a Breakthrough Medical Device Trial in Women’s Health

Medical device trials are inherently challenging, particularly in women’s health. Add the pandemic context and the hurdles can seem insurmountable: particularly within a pandemic environment.

Augmented ePRO for Clinical Trials

ObvioHealth’s Augmented ePRO combines AI-assisted ePRO instruments with a centralized clinical rating platform, all designed to deliver more accurate outcomes.

Stop Missing Your Enrollment Milestones

Targeted digital recruitment and enrollment can get you back on track.

Decentralized Clinical Trials: A Comprehensive Synopsis

ObvioHealth highlight the benefits of incorporating DCTs, as well as the challenges associated with DCTs and call out specific use cases for DCTs.

Your DCT Expert for Clinical Trials in Europe

ObvioHealth has successfully conducted DCTs in many EU countries. Let us equip you with answers so you can make smart decisions about your trial design. Learn more here.

News & Insights

A title image/graphic that matches the headline.

ObvioHealth Ranked on Inc. 5000’s List of Fastest Growing Private Companies for Second Consecutive Year

ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trial solutions, announces today its inclusion in Inc. Magazine’s annual list of the nation’s fastest-growing private companies.

DTx in mental health: The Expanding Role of Digital Therapeutics in Equitable, Accessible Mental Health Care

Digital therapeutics are playing an increasing role in mental health care. Ensuring that these DTx products meet quality thresholds is key to effective care.

BYOD ePRO Models Are Transforming Long-Term Follow-Ups

BYOD ePRO models deliver a range of benefits to clinical trial stakeholders, including increased engagement, reduces site team burden and more.

ePRO CNS: How DCT Solutions Address Four Key Challenges in Central Nervous System Research

Let’s dive into how decentralized clinical trials (DCTs), leveraging a modular approach, can address four key challenges in central nervous system research

ObvioHealth Expands Digital Health Research Ecosystem Through New Global Licensing Agreement With Dedalus

The extended partnership includes access to Dedalus’s robust data mining technology to facilitate the ingestion, harmonization, and analysis of patient data

Digital Therapeutic (DTx) Integration Guide | ObvioHealth

Digital Therapeutic (DTx) Integration Guide: How to Choose the Best Fit for Your Clinical Trial

When it comes to clinical trials, DCT and digital therapeutic (DTx) companies are natural partners. Both are tech savvy and adept in digital health

Meta-Analysis: ePRO Compliance and Retention for Patients using their own Smartphones in Fully Decentralized Clinical Trials

Traditionally, electronic patient reported outcomes (ePRO) were collected on provisioned devices provided by clinical sites. Patient retention in clinical trials depended largely on the sites’ ability to engage patients during visits. The arrival of “bring your own device” (BYOD) models has enabled patients to complete ePRO in clinical trials using their own smartphones.

Opening Airways with Technology: A Meta Review of Digital Diagnostic Solutions for Childhood Pneumonia

Though incidences of pneumonia have decreased overall, the disease is the leading infectious cause of death in children globally, affecting 1 in 6 child deaths.

ObvioHealth Develops Novel Digital Instruments to Reduce Subjectivity while Increasing Compliance in Pediatric Clinical Trials

ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trial solutions, announces the development of two novel digital instruments to increase accuracy and reduce patient/caregiver burden in pediatric clinical trials.

Pediatric Clinical Trial Support | ObvioHealth

All in the Family: How Decentralized Clinical Trials Support Children and Caregivers in Pediatric Research

Decentralized clinical trials offer an effective avenue to mitigate the issues that typify pediatric clinical trials, including patient-reported data accuracy.

eConsent Clinical Trials

eConsent can mitigate these shortcomings by providing flexibility and engagement that empower patients with information and sponsors with data integrity.

Overcoming Challenges in Women’s Health Clinical Trials through a DCT Approach

In our experience in women’s health studies, we’ve found that decentralization can provide an avenue for overcoming barriers in women’s health clinical trials.

ObvioHealth Completes First Fully Virtual Urogynecology Clinical Trial

ObvioHealth, a leading global Virtual Research Organization (VRO) delivering end-to-end decentralized clinical trial solutions, announces it has completed the first fully virtual urogynecology study in partnership with trial sponsor, Renovia, Inc. (Renovia). The trial validated the efficacy of Renovia’s leva® Pelvic Health System on women’s incontinence, a health concern that affects 62% of U.S. adult women.

Artificial Intelligence Meets ePRO | ObvioHealth

Artificial Intelligence Meets ePRO: Leveraging AI-Assisted Technologies to Capture and Assess Unstructured Data

One of the keys to optimizing ePRO is deploying artificial intelligence (AI) to support human participants and clinical teams.

Debunking DCT Myths, Part 2: Tackling Misconceptions about Study Design and Acceptance

Debunking DCT Myths, Continued

In our conversations with trial sponsors, ObvioHealth often tackles common misconceptions about decentralized clinical trials (DCTs). These myths hinder our industry’s evolution by keeping sponsors from designing optimal trials that deliver better data with higher retention and compliance rates.

Decentralized Clinical Trial Myths

ObvioHealth tackles misconceptions about decentralized clinical trials, they’re less safe, they’re always fully virtual, the data isn’t trustworthy, and so on.

ObvioHealth and 1nHealth Launch Initiative to Rescue Clinical Trials Struggling to Transition to Decentralization

ObvioHealth and 1nHealth announce today a joint initiative to smooth the transition to hybrid and decentralized clinical research. The initiative focuses on supporting clinical trials that may be struggling due to suboptimal protocol design, imprecise recruitment strategies, maladapted technology options or ailing site teams.According to clinicaltrials.gov, there are about 1,600 suspended trials at present.

ePRO and Expert Rating: Shifting the Data Assessment Paradigm for More Accurate Outcomes

Combining the ease of ePRO with expert rating—patient convenience with the objectivity of experts—facilitates more accurate data collection.

Inter-Rater Variability

This study collected and compared stool ratings from caregivers (Group A), central raters (Group B), and pediatric gastroenterologists (Group C) to discover whether the level of stool consistency of a given photo is more prone to inter-rater variability. The study's results evidence inter-rater variability that is different across Bristol Stool Scale (BSS), which motivates research into standardized training or automated scoring, with a special emphasis on BSS.

Vaccine Clinical Trials are Ripe for Virtualization

Expectations for the time it takes to complete a vaccine clinical trial have been radically raised by the mRNA vaccines’ successes.

Electronic Patient-Reported Outcomes | ObvioHealth

Digital Instruments are Transforming Electronic Patient-Reported Outcomes

Enhancing Electronic Patient-Reported Outcomes with digital instruments streamlines and accelerates data collection, making clinical trials more accessible.

4 Clinical Trial Trends for 2022: Better patient data with less patient effort

Moving into 2022, decentralized models, propelled by breakthroughs in digital technology, will continue to reshape the industry, improving trial outcomes

Diversity in Clinical Trials

Diversity in Clinical Trials is a longstanding challenge in clinical research and has only been underscored by the outcomes of the pandemic.

APAC Clinical Trials: Is Decentralized the Next Frontier?

Rapid growth in the Asia-Pacific (APAC) clinical research market has created strong opportunities for conducting decentralized clinical trials in the region.

How Decentralized Trials Can Maximize Recruitment and Engagement for “Taboo” Research Topics

DCTs offer an effective avenue for studying what are sometimes considered “taboo” therapeutic areas while respecting participants’ discretion.

News - Novotech and ObvioHealth are Finalists for the Clinical Partnership of the Year Citeline Award 2021

ObvioHealth & Novotech: Finalists for Clinical Partnership Award

Novotech, a leading biotech specialist CRO in the Asia-Pacific region, and virtual research organization (VRO) partner ObvioHealth have been selected as finalists for the Clinical Partnership of the Year Citeline Award by Informa Pharma Intelligence. ObvioHealth is Novotech’s preferred provider for virtual clinical trials in APAC, while Novotech is ObvioHealth’s preferred CRO in the region for hybrid and virtual trials.

ObvioHealth Partners with Anatara Lifesciences to Launch First-of-its-kind Decentralized Clinical Trial in Australia

NEW YORK, September 30, 2021 - ObvioHealth, a global Virtual Research Organization (VRO), today announces the launch of a first-of-its kind clinical trial in Australia, using a combination of in-home data collection methods that will reduce and in some cases eliminate the need for follow-up visits to clinics.

ObvioHealth Announces Key C-Suite Hires, Plans to Add 20 Jobs by Year’s End

NEW YORK – September 14, 2021 - ObvioHealth, a global virtual research organization (VRO), announces key hires to round out its executive leadership team. Seeded four years ago by SGI, ObvioHealth has entered into a phase of more rapid growth and a need for an upsized team to address market demand.

ObvioHealth Ranked No. 390 on Inc. 5000’s 2021 List of Fastest Growing Private Companies

NEW YORK – August 17, 2021 - Inc. Magazine today ranked ObvioHealth, a leading global Virtual Research Organization (VRO), at No. 390 on its annual list of the nation’s fastest-growing private companies, confirming ObvioHealth’s impressive growth in the decentralized clinical trials (DCT) space.

Strategies to Support Clinical Trials in Older Adults

Decentralized trials (DCTs) expand older adults’ access to trials, allowing them to participate at higher rates.

ObvioHealth Announces Scott Clark as Chief Commercial Officer

Introducing Scott Clark as ObvioHealth's Chief Commercial Officer. Scott has had a distinguished and successful 25-year career in developing successful commercial strategies for global enterprises in the pharmaceutical, biotechnology, healthcare and technology industries.

How to Virtualize Pain Clinical Trials: 5 Elements of a Successful Study

Pain is a universal human experience—and finding ways to relieve or better manage it continues to be a priority for the life sciences.

Clinician Versus Caregiver Ratings of Pediatric Stool Consistency

In a recent study, we found that caregivers both underreported and overreported certain stool consistencies compared to clinician ratings. We need to make it easier for parents to report in clinical trials. See why digital image capture is an improved method for assessments of treatment efficacy and health status for pediatric GI research.

Automatic Image Segmentation to Preprocess Pediatric Stool Photos

Unstructured data collection from image capture technology can be harnessed to improve the quality of patient-reported data and serve as the bedrock for the training of new algorithms that can help clinicians more accurately diagnose disease.

Patient-Centric Clinical Trials

We know that a patient-centric approach to clinical trials generally leads to higher compliance and retention rates. DCTs are more convenient for participants.

ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally

ObvioHealth, a global Virtual Research Organization(VRO), announces it has raised $31 million in its latest round of financing.The round was led by two new partners: Dedalus Group, an international healthcare IT and diagnostic software provider, leader in Europe and backed by Ardian, and Novotech Health Holdings Pte. Ltd.(“Novotech”), Asia Pacific’s highest revenue biotech-specialistCRO in 2020.

ObvioHealth Announces a Groundbreaking Partnership with Dedalus Group to Unite Real World & Clinical Trial Data

NEW YORK – June 7, 2021 – ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.

News - ObvioHealth Announces Partnership with Hyfe, Integrating AI Technology for Tracking and Analyzing Coughs to Expand Data Tools for Decentralized Clinical Trials

ObvioHealth Announces Partnership with Hyfe, Integrating AI Technology for Tracking and Analyzing Coughs to Expand Data Tools for Decentralized Clinical Trials

ObvioHealth will integrate Hyfe's technology into its decentralized clinical trials platform and smartphone app to capture and analyze coughing events.

Coming Full Circle to Build a Regional Tech Hub in Singapore

ObvioHealth looks to grow expertise in deep tech. We immediately recognized that Singapore could fill this need. Here, we can tap into a rich ecosystem of health tech companies and talent.

News - ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date

ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date

ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals.

ObvioHealth Announces Next Generation Virtual Research Platform and Ecosystem

ObvioHealth, a global Virtual Research Organization (VRO), announces its next generation platform offering enhanced remote patient monitoring capabilities for the company’s end-to-end decentralized clinical trial solutions.

ObvioHealth and GI Alliance Partner to Bring Better GI Care to Patients

ObvioHealth, a global virtual research organization (VRO), and GI Alliance, one of the nation's largest independent gastroenterology services organization, jointly announce anew partnership to create better clinical trial experiences through the use of decentralized clinical trial designs.

3 Reasons Why Patients Prefer Virtual Clinical Trials

Site visits pose many problems for clinical trial sponsors, especially during the ongoing pandemic. However, research can continue with minimized risk for all involved when done virtually.

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

ObvioHealth, a full-service virtual research organization (VRO), announces today a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

COVID-19 drug development has brought a unique set of clinical challenges, virtual patient training and decentralized trials can be part of the solution.

ObvioHealth Secures $17 Million in Latest Investment Round

ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.

Virtual Research: 5 Advantages of the New Normal

More now than ever, virtual research methods are being adopted by those in the scientific community. The advantages of “going digital” are simply too great to pass up.

Enrollment Completed for Virtual Dermatology Study

ObvioHealth is excited to announce the completion of enrollment for its latest completely virtual research study. Our digital, disruption-free, approach to recruitment allowed participants to enroll from the safety of their homes.

Coronavirus Outbreak: Medical Staff Vulnerable, Telemedicine the Solution?

Medical personnel working on the frontline to prevent the spread of the COVID-19 (coronavirus) are susceptible to infection, we believe telemedicine can help to mitigate this risk.

ObvioHealth Launches Virtual COVID-19 Symptoms & Immune Response Registry

Singapore and New-York, 2 April 2020 – ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.

Infographic: The Path to Better Data via Virtual Trials

A research study designed around the needs of its participants is more likely to deliver better data, a product of optimized compliance and engagement. By pairing a versatile digital solution with an accommodating protocol design, ObvioHealth can offer maximum convenience to those who matter most: the people who produce the data. The result? A collection of real-world data points and enhanced insights.

Patient Interactions: Sustained Engagement via Digital Communication

In the clinical trial space, patient concerns that must be addressed with tact. Whether delivering potentially life-altering news, or discussing a health-related concern, I find digital interaction to be the most prudent approach to sustaining engagement and reducing dropout. Here are five real-life examples of this strategy at-work.

Real World Data and Evidence Revolutionize Clinical Research

The U.S. FDA is aware the drug approval process can often be strenuous, consuming large amounts of time and money. That’s why they’ve made a commitment to consider real-world evidence in the approval of new drug indications resulting in a more efficient approach for manufacturers.

Going Virtual: Succeeding Where Traditional Clinical Trials Fail

ObvioHealth, a digital CRO, recently completed a clinical trial solely using a virtual site model (no physical site visits) which would have likely proved futile in the traditional study format, of which requires multiple site visits. This article will further analyze the rationale behind this claim.

PI Perspective: Our Formula to Curb Clinical Trial Dropouts

Our team recently completed a clinical trial tasked with measuring the efficacy of a dietary supplement as an intervention for adults with an elevated blood pressure, or stage I hypertension. By employing a hybrid study model, sustaining patient engagement, and reducing resources required of the patient and study team, we successfully beat the dropout allowance.

Infographic: Resource Consumption by Clinical Trial Type

All clinical trials require resource consumption from both the study team and participant. The following infographic will detail the differences in resources required in the digital (hybrid) model compared to that of the traditional “brick and mortar” model.

An Alternate Approach to the Traditional Recruitment Nightmare

Digital patient-centric clinical trials (PCT) are often carried out in the hybrid setting (minimizing site visits and maximizing the use of a virtual site), or the site-less setting (solely using the virtual site). The pairing of a digitalized PCT with social media targeting increases the probability of successful enrollment.

New Clinical Trial Begins to Measure Efficacy of an Herbal Blend on Menopausal Symptoms

*UPDATE: Enrollment has been filled for this study.* We’re pleased to announce recruitment is underway for our latest research study.

PI Perspective: Patient Engagement in a Digital Trial

I’ve been involved in clinical research in the traditional “brick and mortar site” setting, and now, in my current role as a principal investigator (PI) for ObvioHealth, in the digital “virtual site” setting.

4 Scenarios for Using Virtual Clinical Trials

Digital technology can now enable collecting data from participants in their homes, during their everyday lives, instead of inconvenient, costly trips to the clinic. It’s as simple as having a smart phone.

12 questions to ask before participating in a clinical research trial

There are more than 270,000 clinical research trials going on in the U.S. and other countries currently listed on ClinicalTrials.gov. These trials are helping to advance medial research for better treatments of diseases and conditions. However, before decided to participate in one, there are a number of items to consider first.

Diversity in Clinical Trial Enrollment: Exploring the Roadblocks to Minority Participation in Clinical Research

In the first part of our two-piece series exploring minority participation in clinical trial research, we examine the numerous challenges to securing diversity in clinical trials, and the consequences of primarily white patient populations.

Compliance Problems? 5 Ways Digital Tech Can Help

Inconvenience to the subject and infrequent engagement with the study team often lead to low compliance. Digital technology, such as ClaimIt, makes it easier for subjects to adhere to the protocol.

If I participate in a clinical trial how will my data be used?

Data collected from you as a participant is called individual participant data (IPD), that information is transformed into de-identified data when researchers do their analyses, meaning the ability to determine the identity of an individual participant is removed from the data.

News - Infographic: Digital vs. Traditional Clinical Trial Design

1: Study Design & Set up

2: Recruitment & Prescreening

3: Enrollment & Onboarding

4: Logistics Management

5: Outcomes Measurement & Remote Monitoring

6: Medical Assessment & Clinical Oversight

7: Reporting & Data Visualization

8: Regulatory, Data Privacy & Security

Therapeutic Areas

Sectors

Latest Case Studies

Cookie Policy

Featured News & Insights